UTHR

542.66

0.13% -0.73

Dopo l'orario di chiusura: 542.66

United Therapeutics Corp (UTHR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché UTHR Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$543.39

Aprire:

$544.37

Volume 24 ore:

1.02M

Relative Volume:

2.00

Capitalizzazione di mercato:

$23.03B

Reddito:

$3.17B

Utile/perdita netta:

$1.29B

Rapporto P/E:

20.03

EPS:

27.0947

Flusso di cassa netto:

$1.01B

1 W Prestazione:

+1.13%

1M Prestazione:

-6.18%

6M Prestazione:

+7.00%

1 anno Prestazione:

+91.02%

Intervallo 1D:

$535.44

$554.51

Intervallo di 1 settimana:

$533.49

$555.32

Portata 52W:

$272.12

$609.35

United Therapeutics Corp Stock (UTHR) Company Profile

Nome

United Therapeutics Corp

Settore

Healthcare (1096)

Industria

Drug Manufacturers - Specialty & Generic (86)

Telefono

(301) 608-9292

Indirizzo

1000 SPRING ST, SILVER SPRING, MD

Dipendente

1,400

Cinguettio

Prossima data di guadagno

2026-07-29

Ultimi documenti SEC

UTHR's Discussions on Twitter

Compare UTHR vs TAK, HLN, TEVA, ZTS

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
UTHR United Therapeutics Corp	542.66	23.03B	3.17B	1.29B	1.01B	27.09
TAK Takeda Pharmaceutical Co Adr	15.91	50.27B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.24	40.72B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	33.21	38.67B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.09	31.90B	9.51B	2.64B	2.14B	6.0361

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-10	Iniziato	Raymond James	Outperform
2025-10-20	Iniziato	Wells Fargo	Underweight
2025-09-26	Iniziato	RBC Capital Mkts	Outperform
2025-06-02	Iniziato	Cantor Fitzgerald	Overweight
2025-04-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-04-21	Aggiornamento	BofA Securities	Underperform → Neutral
2024-07-11	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-02-12	Aggiornamento	Goldman	Sell → Neutral
2024-02-05	Iniziato	Leerink Partners	Outperform
2023-12-08	Iniziato	Wells Fargo	Overweight
2022-12-06	Iniziato	UBS	Buy
2022-12-05	Iniziato	Goldman	Sell
2022-10-11	Iniziato	Morgan Stanley	Overweight
2022-09-20	Reiterato	BofA Securities	Underperform
2022-09-19	Ripresa	Wedbush	Outperform
2022-02-11	Iniziato	BTIG Research	Neutral
2021-07-14	Aggiornamento	Argus	Hold → Buy
2021-04-26	Ripresa	Credit Suisse	Outperform
2021-02-01	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-09-14	Ripresa	JP Morgan	Overweight
2020-06-25	Reiterato	H.C. Wainwright	Neutral
2020-03-10	Aggiornamento	Jefferies	Hold → Buy
2020-02-27	Aggiornamento	Cowen	Market Perform → Outperform
2020-01-31	Aggiornamento	JP Morgan	Neutral → Overweight
2019-12-03	Iniziato	BofA/Merrill	Underperform
2019-08-01	Aggiornamento	Jefferies	Underperform → Hold
2019-08-01	Aggiornamento	Ladenburg Thalmann	Neutral → Buy
2019-07-01	Aggiornamento	Credit Suisse	Neutral → Outperform
2019-05-17	Aggiornamento	UBS	Sell → Neutral
2019-05-09	Aggiornamento	Credit Suisse	Underperform → Neutral
2018-10-12	Aggiornamento	Standpoint Research	Hold → Buy
2018-08-08	Downgrade	Credit Suisse	Neutral → Underperform
2018-04-03	Aggiornamento	Credit Suisse	Underperform → Neutral
2018-02-22	Reiterato	Barclays	Underweight
2018-01-18	Ripresa	Credit Suisse	Underperform
2017-12-27	Reiterato	Wedbush	Outperform
2017-04-27	Reiterato	Wedbush	Outperform
2017-03-30	Iniziato	UBS	Sell
2017-03-16	Iniziato	Credit Suisse	Underperform

Mostra tutto

United Therapeutics Corp Borsa (UTHR) Ultime notizie

Jun 26, 2026

United Therapeutics CEO Martine Rothblatt sells $5.2m in shares By Investing.com - Investing.com South Africa

Jun 26, 2026

United Therapeutics CEO Martine Rothblatt sells $5.2m in shares - Investing.com

Jun 26, 2026

Form 4 United Therapeutics Corporation For: 26 June By Investing.com - Investing.com Canada

Jun 26, 2026

United Therapeutics Corp Annual Shareholders Meeting Transcript - GuruFocus

Jun 26, 2026

Martine A. Rothblatt sells $5.2m United Therapeutics shares - Investing.com UK

Jun 26, 2026

Jun 25, 2026

Martine A. Rothblatt sells $5.2m United Therapeutics shares By Investing.com - Investing.com Nigeria

Jun 25, 2026

Form 4 United Therapeutics Corporation For: 25 June By Investing.com - Investing.com Canada

Jun 25, 2026

Jun 24, 2026

United Therapeutics chairperson & CEO sells $5.17m in stock - Investing.com UK

Jun 24, 2026

United Therapeutics chairperson & CEO sells $5.17m in stock By Investing.com - Investing.com South Africa

Jun 24, 2026

United Therapeutics CEO Rothblatt sells $5.1m in UTHR shares By Investing.com - Investing.com South Africa

Jun 24, 2026

Form 4 United Therapeutics Corporation For: 24 June By Investing.com - Investing.com Australia

Jun 24, 2026

United Therapeutics CEO Rothblatt sells $5.1m in UTHR shares - Investing.com

Jun 24, 2026

United Therapeutics - Forbes

Jun 24, 2026

Jun 22, 2026

Martine Rothblatt, United Therapeutics CEO, sells $5.1m in stock By Investing.com - Investing.com Australia

Jun 22, 2026

Form 4 United Therapeutics Corporation For: 22 June By Investing.com - Investing.com Australia

Jun 22, 2026

Martine Rothblatt, United Therapeutics CEO, sells $5.1m in stock - Investing.com

Jun 22, 2026